Table 4. Multivariate analysis of relations between clinicopathological variables and overall survival.
Full model | |||||
---|---|---|---|---|---|
Clinicopathological variables | Total N | Hazard Ratio | p-value | Lower 95% | Upper 95% |
SLC2A1 (GLUT1) | 339 | 1.0043 | 0.9449 | 0.8881 | 1.1359 |
SLC2A2 (GLUT2) | 0.9096 | 0.0299* | 0.8351 | 0.9908 | |
GENDER | 0.8409 | 0.1936 | 0.5745 | 1.2310 | |
AGE (continuous) | 1.0096 | 0.1936 | 0.9952 | 1.0241 | |
STAGE (I or II vs III or IV) | 2.3301 | < 0.001*** | 1.6015 | 3.3918 | |
Selected Model (using stepwise method) | |||||
Clinicopathological variables | Total N | Hazard Ratio | p-value | Lower 95% | Upper 95% |
SLC2A2 (GLUT2) | 339 | 0.9097 | 0.0145* | 0.8433 | 0.9814 |
AGE (continuous) | 1.0105 | 0.1459 | 0.9964 | 1.0249 | |
Stage (I or II vs III or IV) | 2.3498 | < 0.001*** | 1.6154 | 3.4182 |